ClinicalTrials.Veeva

Menu

Intravenous Lidocaine in Children Undergoing Laparoscopic Appendectomy

M

Medical University of Warsaw

Status and phase

Completed
Phase 4

Conditions

Postoperative Pain
Postoperative Nausea and Vomiting
Acute Appendicitis

Treatments

Drug: Lidocaine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Intravenous lidocaine - a potent local anesthetic with analgesic and anti-inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and facilitates pain management in adults. In children population promising but limited evidence is available. The study was planned to evaluate the efficacy of continuous intravenous infusion of lidocaine to reduce opioid consumption during and after laparoscopic appendectomy in children.

Full description

Postoperative pain in children is still one of the most under diagnosed and under treated medical problems. It affects post-surgery recovery, mortality and morbidity, limits mobility. Untreated pain not only causes child's suffering but can decrease the pain threshold in the future or lead to the development of chronic pain. Postoperative analgesia has been traditionally based on opioids but as their use can be associated with adverse effects prolonging hospital stay and affecting recovery current guidelines focus on multimodal approaches involving numerous analgesics with different mechanism of action. Growing evidence suggests that intravenous lidocaine reduces intra- and postoperative requirement for opioids. Lidocaine has been proved to have analgesic and anti-inflammatory properties. It is also a potent peripheral nervous system modulator inhibiting peripheral and central sensitization. The studies performed in adult population have proved the efficacy of systemic lidocaine in postoperative pain treatment. It is an effective adjunct that reduces opioids consumption and facilitates pain management. As such lidocaine infusion has been included in postoperative pain management guidelines for adults. Studies on children population have promising results but high quality randomized controlled trials are still missing.

The proposed study has been planned to evaluate the efficacy of continuous infusion of lidocaine as an adjunct to standard general anesthesia (involving fentanyl and sevoflurane) in reducing opioids consumption and facilitating postoperative pain control in children undergoing laparoscopic appendectomy.

Enrollment

74 patients

Sex

All

Ages

18 months to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age between 18 months and 18 year-old
  2. Patients with American Society of Anaesthesiologists physical status (ASA) class 1/1E, 2/2E, 3/3E
  3. Patients undergoing laparoscopic appendectomy

Exclusion criteria

  1. Allergy to local anesthetics or contraindication to use of lidocaine
  2. Patients with American Society of Anaesthesiologists physical status (ASA) IV or more.
  3. Severe cardiovascular disease
  4. Preoperative bradycardia
  5. Preoperative atrioventricular block
  6. Renal failure
  7. Chronic treatment with analgesics
  8. Parents' refusal

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

74 participants in 2 patient groups

Group A - lidocaine group
Experimental group
Description:
Group A: children receiving standard general anesthesia with intravenous lidocaine infusion 1,5 mg/kg for 5 minutes before induction of anesthesia. After 5 minutes, lidocaine infusion continued at rate of 1.5 mg/kg/h during operation, and discontinued before move the patients to PACU.
Treatment:
Drug: Lidocaine
Group B - control group
No Intervention group
Description:
Group B: children receiving standard general anesthesia (involving fentanyl and sevoflurane) without lidocaine infusion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems